Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH14 DNAH12 DNAH6 DNAH9 DNAH11	3.21e-07	18	169	5	GO:0008569
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNAH14 DNAH12 DNAH6 DNAH9 DNAH11	3.44e-06	28	169	5	GO:0051959
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNAH14 DNAH12 DNAH6 DNAH9 DNAH11	1.43e-05	37	169	5	GO:0045505
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYH7 MYH7B DNAH14 DNAH12 DNAH6 DNAH9 DNAH11	6.58e-05	118	169	7	GO:0003774
GeneOntologyMolecularFunction	polysaccharide binding	CLEC18A CLEC18B CLEC18C AGL	1.30e-04	31	169	4	GO:0030247
GeneOntologyMolecularFunction	microtubule motor activity	DNAH14 DNAH12 DNAH6 DNAH9 DNAH11	3.18e-04	70	169	5	GO:0003777
GeneOntologyMolecularFunction	DNA topoisomerase type I (single strand cut, ATP-independent) activity	TOP3B TOP1	4.23e-04	4	169	2	GO:0003917
GeneOntologyMolecularFunction	structural constituent of muscle	OBSCN DMD MYBPC1 MYBPC2	4.72e-04	43	169	4	GO:0008307
GeneOntologyBiologicalProcess	cellular anatomical entity morphogenesis	MYH7 SLC9A8 KIAA0319L OBSCN EP300 VPS13B MYBPC1 MYBPC2	4.65e-05	156	170	8	GO:0032989
GeneOntologyBiologicalProcess	cellular component assembly involved in morphogenesis	MYH7 SLC9A8 KIAA0319L OBSCN EP300 VPS13B MYBPC1 MYBPC2	4.65e-05	156	170	8	GO:0010927
GeneOntologyBiologicalProcess	cilium movement involved in cell motility	TTLL3 KIAA0319L DNAH14 DNAH12 CFAP57 DNAH6 DNAH9 ODAD3 DNAH11	6.35e-05	210	170	9	GO:0060294
GeneOntologyBiologicalProcess	cilium movement	TTLL3 KIAA0319L DNAH14 DNAH12 CFAP57 DNAH6 DNAH9 ODAD3 JHY DNAH11	6.39e-05	261	170	10	GO:0003341
GeneOntologyBiologicalProcess	cilium-dependent cell motility	TTLL3 KIAA0319L DNAH14 DNAH12 CFAP57 DNAH6 DNAH9 ODAD3 DNAH11	7.61e-05	215	170	9	GO:0060285
GeneOntologyBiologicalProcess	cilium or flagellum-dependent cell motility	TTLL3 KIAA0319L DNAH14 DNAH12 CFAP57 DNAH6 DNAH9 ODAD3 DNAH11	7.61e-05	215	170	9	GO:0001539
GeneOntologyBiologicalProcess	striated muscle cell development	MYH7 OBSCN DMD EP300 MYBPC1 MYBPC2	9.47e-05	89	170	6	GO:0055002
GeneOntologyBiologicalProcess	sarcomere organization	MYH7 OBSCN EP300 MYBPC1 MYBPC2	1.25e-04	59	170	5	GO:0045214
GeneOntologyBiologicalProcess	chromatin remodeling	ATR RBBP4 RBBP7 NSD2 CHD9 BCL7A BCOR ZBTB7A CBX5 NFRKB CDYL MAEL KDM4A APOBEC3C CDK1 TOP1 EP300	1.39e-04	741	170	17	GO:0006338
GeneOntologyCellularComponent	myosin filament	MYH7 MYH7B OBSCN MYBPC1 MYBPC2	1.47e-06	25	168	5	GO:0032982
GeneOntologyCellularComponent	dynein complex	DNAH14 DNAH12 DNAH6 DNAH9 DNAH11	7.27e-05	54	168	5	GO:0030286
GeneOntologyCellularComponent	RZZ complex	ZWILCH ZW10	1.92e-04	3	168	2	GO:1990423
GeneOntologyCellularComponent	myofibril	MYH7 MYH7B OBSCN STYXL2 RYR2 MMP2 DMD MYBPC1 MYBPC2	3.76e-04	273	168	9	GO:0030016
GeneOntologyCellularComponent	supramolecular fiber	ZWILCH MYH7 KRT9 TTLL3 DCDC1 MYH7B OBSCN STYXL2 DNAH14 RYR2 DNAH12 CDK1 MMP2 DMD ZW10 DNAH6 DNAH9 MYBPC1 DNAH11 COL1A1 MYBPC2	5.19e-04	1179	168	21	GO:0099512
GeneOntologyCellularComponent	supramolecular polymer	ZWILCH MYH7 KRT9 TTLL3 DCDC1 MYH7B OBSCN STYXL2 DNAH14 RYR2 DNAH12 CDK1 MMP2 DMD ZW10 DNAH6 DNAH9 MYBPC1 DNAH11 COL1A1 MYBPC2	5.67e-04	1187	168	21	GO:0099081
GeneOntologyCellularComponent	contractile muscle fiber	MYH7 MYH7B OBSCN STYXL2 RYR2 MMP2 DMD MYBPC1 MYBPC2	5.82e-04	290	168	9	GO:0043292
GeneOntologyCellularComponent	A band	OBSCN RYR2 MYBPC1 MYBPC2	8.07e-04	52	168	4	GO:0031672
GeneOntologyCellularComponent	sarcomere	MYH7 OBSCN STYXL2 RYR2 MMP2 DMD MYBPC1 MYBPC2	9.38e-04	249	168	8	GO:0030017
GeneOntologyCellularComponent	host intracellular region	GBP6 GBP4	9.43e-04	6	168	2	GO:0043656
GeneOntologyCellularComponent	host cell cytoplasm	GBP6 GBP4	9.43e-04	6	168	2	GO:0030430
GeneOntologyCellularComponent	host cell part	GBP6 GBP4	9.43e-04	6	168	2	GO:0033643
GeneOntologyCellularComponent	host intracellular part	GBP6 GBP4	9.43e-04	6	168	2	GO:0033646
GeneOntologyCellularComponent	host cell cytoplasm part	GBP6 GBP4	9.43e-04	6	168	2	GO:0033655
GeneOntologyCellularComponent	symbiont-containing vacuole	GBP6 GBP4	9.43e-04	6	168	2	GO:0020003
GeneOntologyCellularComponent	symbiont-containing vacuole membrane	GBP6 GBP4	9.43e-04	6	168	2	GO:0020005
GeneOntologyCellularComponent	axonemal dynein complex	DNAH12 DNAH6 DNAH9	1.03e-03	25	168	3	GO:0005858
GeneOntologyCellularComponent	NURF complex	RBBP4 RBBP7	1.31e-03	7	168	2	GO:0016589
GeneOntologyCellularComponent	axoneme	TTLL3 DNAH12 DNAH6 DNAH9 ODAD3 DNAH11 BRWD1	1.45e-03	207	168	7	GO:0005930
GeneOntologyCellularComponent	ciliary plasm	TTLL3 DNAH12 DNAH6 DNAH9 ODAD3 DNAH11 BRWD1	1.50e-03	208	168	7	GO:0097014
GeneOntologyCellularComponent	M band	OBSCN MYBPC1 MYBPC2	1.94e-03	31	168	3	GO:0031430
Domain	Dynein_heavy_chain_D4_dom	DNAH14 DNAH12 DNAH6 DNAH9 DNAH11	1.04e-07	14	168	5	IPR024317
Domain	AAA_8	DNAH14 DNAH12 DNAH6 DNAH9 DNAH11	1.04e-07	14	168	5	PF12780
Domain	DHC_fam	DNAH14 DNAH12 DNAH6 DNAH9 DNAH11	1.55e-07	15	168	5	IPR026983
Domain	Dynein_heavy	DNAH14 DNAH12 DNAH6 DNAH9 DNAH11	1.55e-07	15	168	5	PF03028
Domain	Dynein_heavy_dom	DNAH14 DNAH12 DNAH6 DNAH9 DNAH11	1.55e-07	15	168	5	IPR004273
Domain	Dynein_HC_stalk	DNAH14 DNAH6 DNAH9 DNAH11	5.89e-06	14	168	4	IPR024743
Domain	Dynein_heavy_dom-2	DNAH12 DNAH6 DNAH9 DNAH11	5.89e-06	14	168	4	IPR013602
Domain	DHC_N2	DNAH12 DNAH6 DNAH9 DNAH11	5.89e-06	14	168	4	PF08393
Domain	ATPase_dyneun-rel_AAA	DNAH12 DNAH6 DNAH9 DNAH11	5.89e-06	14	168	4	IPR011704
Domain	MT	DNAH14 DNAH6 DNAH9 DNAH11	5.89e-06	14	168	4	PF12777
Domain	AAA_5	DNAH12 DNAH6 DNAH9 DNAH11	5.89e-06	14	168	4	PF07728
Domain	CAF1C_H4-bd	RBBP4 RBBP7	2.40e-04	3	168	2	PF12265
Domain	Histone-bd_RBBP4_N	RBBP4 RBBP7	2.40e-04	3	168	2	IPR022052
Domain	CAP	CLEC18A CLEC18B CLEC18C	3.00e-04	15	168	3	PF00188
Domain	SCP	CLEC18A CLEC18B CLEC18C	3.00e-04	15	168	3	SM00198
Domain	Allrgn_V5/Tpx1	CLEC18A CLEC18B CLEC18C	3.00e-04	15	168	3	IPR001283
Domain	-	CLEC18A CLEC18B CLEC18C	3.00e-04	15	168	3	3.40.33.10
Domain	CAP_domain	CLEC18A CLEC18B CLEC18C	3.00e-04	15	168	3	IPR014044
Domain	AAA	ABCC1 ABCA7 DNAH12 DNAH6 TAP1 DNAH9 DNAH11	3.29e-04	144	168	7	SM00382
Domain	AAA+_ATPase	ABCC1 ABCA7 DNAH12 DNAH6 TAP1 DNAH9 DNAH11	3.29e-04	144	168	7	IPR003593
Domain	WD40_repeat_dom	RBBP4 RBBP7 UBR4 NOL11 EDC4 DCAF5 BRWD3 CFAP57 RIC1 BRWD1	3.67e-04	297	168	10	IPR017986
Domain	GRAM	MTMR1 TBC1D8B GRAMD1B	3.67e-04	16	168	3	SM00568
Domain	Kelch_1	KLHL10 KLHDC2 KLHL30 ATRNL1 KLHL34	4.19e-04	70	168	5	PF01344
Domain	Kelch_1	KLHL10 KLHDC2 KLHL30 ATRNL1 KLHL34	4.19e-04	70	168	5	IPR006652
Domain	SHR-BD	VPS13C VPS13B	4.77e-04	4	168	2	IPR009543
Domain	Coact_PPARg	FAM120A FAM120C	4.77e-04	4	168	2	IPR026784
Domain	VPS13_C	VPS13C VPS13B	4.77e-04	4	168	2	PF16909
Domain	VPS13_C	VPS13C VPS13B	4.77e-04	4	168	2	IPR031645
Domain	SHR-BD	VPS13C VPS13B	4.77e-04	4	168	2	PF06650
Domain	Autophagy-rel_C	VPS13C VPS13B	7.90e-04	5	168	2	IPR015412
Domain	ATG_C	VPS13C VPS13B	7.90e-04	5	168	2	PF09333
Domain	-	KLHDC2 KLHL30 ATRNL1 KLHL34	9.03e-04	48	168	4	2.120.10.80
Domain	GRAM	MTMR1 TBC1D8B GRAMD1B	9.71e-04	22	168	3	PF02893
Domain	GRAM	MTMR1 TBC1D8B GRAMD1B	9.71e-04	22	168	3	IPR004182
Domain	Chromo_domain	CHD9 CBX5 CDYL	1.26e-03	24	168	3	IPR023780
Domain	Kelch-typ_b-propeller	KLHDC2 KLHL30 ATRNL1 KLHL34	1.51e-03	55	168	4	IPR015915
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	OGFRL1 ZWILCH AKT3 TTLL3 TUT7 FRMPD1 OBSCN NOL11 BCOR DCAF5 GBP4 CANT1 TSR1 P4HB CBX5 ATRNL1 NFRKB MKX HSD3B1 ARHGAP21 VPS13B BRWD1	2.58e-08	1084	173	22	11544199
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	PRUNE2 EVL SLC9A8 TTLL3 RBBP4 NSD2 VPS13C FRMPD1 OBSCN EXOSC3 CHD9 BRWD3 DNAH14 GDE1 ZBTB7A PTPRB FAM120A FAM120C RIMS1 MMP16 COPS5 EP300 VPS13B RIC1 ZC3HAV1	1.06e-07	1489	173	25	28611215
Pubmed	Human CLEC18 Gene Cluster Contains C-type Lectins with Differential Glycan-binding Specificity.	CLEC18A CLEC18B CLEC18C	1.21e-07	3	173	3	26170455
Pubmed	The C-type lectin-like domain superfamily.	CLEC18A CLEC18B CLEC18C	1.21e-07	3	173	3	16336259
Pubmed	Endosomal TLR3 co-receptor CLEC18A enhances host immune response to viral infection.	CLEC18A CLEC18B CLEC18C	1.21e-07	3	173	3	33603190
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	ABCC1 ATR RBBP4 TUT7 KIAA0319L MCAM ABCA7 GDE1 GRAMD1B MYOF USP5 FAT1 CANT1 HNRNPUL2 P4HB PES1 FAM3C MMP2 IL1RAP TAP1 ARHGAP21 COL1A1	1.53e-07	1201	173	22	35696571
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	RBBP4 RBBP7 NSD2 CHD9 BCOR LIN9 GTF2F2 TSR1 CBX5 PES1 NFRKB CDYL KDM4A TOP1 BRWD1	4.42e-07	608	173	15	36089195
Pubmed	The mannose receptor mediates uptake of soluble but not of cell-associated antigen for cross-presentation.	CLEC18A CLEC18B CLEC18C	4.82e-07	4	173	3	16709836
Pubmed	Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	OBSCN EPB41L5 VAT1L KIAA1586 BCOR TRPM3 MED12L	7.74e-07	101	173	7	10997877
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	DCDC1 RBBP4 RBBP7 NSD2 CHD9 BCL7A BCOR ABCA7 DCAF5 BRWD3 ZBTB7A FAT1 FAM120A FAM120C CBX5 CAPRIN2 NFRKB TOP1 EP300 BRWD1	8.25e-07	1116	173	20	31753913
Pubmed	Interactions of the Antiviral Factor Interferon Gamma-Inducible Protein 16 (IFI16) Mediate Immune Signaling and Herpes Simplex Virus-1 Immunosuppression.	NSD2 EXOSC3 NOL11 DBP EDC4 TSR1 CBX5 PES1 APOBEC3C CDK1 ZC3HAV1	9.69e-07	332	173	11	25693804
Pubmed	Differential expression of C-protein isoforms in developing and degenerating mouse striated muscles.	DMD MYBPC1 MYBPC2	1.20e-06	5	173	3	10024132
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	ABCC1 AKT3 RBBP4 RBBP7 TTI2 UBR4 EXOSC3 EDC4 GRAMD1B MYOF USP5 FAM120A ADSS2 HNRNPUL2 PES1 MKX PTRH2 GID8 CDK1 ZW10 TAP1 ZC3HAV1	3.10e-06	1440	173	22	30833792
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	MYH7 GBP6 ATR RBBP4 RBBP7 NOL11 GRAMD1B MYOF PTPN3 GTF2F2 CSK CDK1 UQCR11 MAPK13 COPS5 ARHGAP21 EP300	3.35e-06	910	173	17	36736316
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	ATR RBBP4 RBBP7 NSD2 UBR4 NOL11 CHD9 USP5 GTF2F2 ADSS2 HNRNPUL2 TSR1 CBX5 PES1 CDK1 TOP1 CWF19L1 EP300	3.45e-06	1014	173	18	32416067
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	RBBP4 RBBP7 NSD2 TUT7 UBR4 NOL11 EDC4 USP5 FAM120A TSR1 P4HB PES1 TOP1 ZC3HAV1	5.48e-06	653	173	14	22586326
Pubmed	Progesterone induced Warburg effect in HEK293 cells is associated with post-translational modifications and proteasomal degradation of progesterone receptor membrane component 1.	ATR UBR4 STYXL2 USP5 CDK1	1.06e-05	58	173	5	31067491
Pubmed	SIRT1 coordinates with the CRL4B complex to regulate pancreatic cancer stem cells to promote tumorigenesis.	RBBP4 RBBP7 CDK1 EP300	1.10e-05	28	173	4	34163012
Pubmed	Wnt regulation: exploring Axin-Disheveled interactions and defining mechanisms by which the SCF E3 ubiquitin ligase is recruited to the destruction complex.	SLC9A8 GBP6 RBBP4 RBBP7 CHD9 EDC4 FAM120A TSR1 P4HB GID8 CDK1 MMP2 DMD TOP1 ARHGAP21	1.41e-05	809	173	15	32129710
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	MACC1 RBBP7 NSD2 EXOSC3 EPB41L5 NOL11 EDC4 BCL7A BCOR LIN9 ZBTB7A MYOF GTF2F2 TSR1 P4HB FAM120C PES1 NFRKB PTRH2 CDYL ZC3HAV1	1.90e-05	1497	173	21	31527615
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	AKT3 RBBP4 RBBP7 TUT7 ADSS2 TRPM3 CSK P4HB CDK1 MMP2 MAPK13 MMP16 EP300 DNAH11	1.90e-05	730	173	14	34857952
Pubmed	The proto-oncoprotein FBI-1 interacts with MBD3 to recruit the Mi-2/NuRD-HDAC complex and BCoR and to silence p21WAF/CDKN1A by DNA methylation.	BCOR ZBTB7A CBX5	1.94e-05	11	173	3	23658227
Pubmed	Crosstalk between RyR2 oxidation and phosphorylation contributes to cardiac dysfunction in mice with Duchenne muscular dystrophy.	RYR2 DMD	2.46e-05	2	173	2	26555638
Pubmed	Down-regulating Myoferlin inhibits the vasculogenic mimicry of melanoma via decreasing MMP-2 and inducing mesenchymal-to-epithelial transition.	MYOF MMP2	2.46e-05	2	173	2	29164766
Pubmed	Fast and slow skeletal myosin binding protein-C and aging.	MYBPC1 MYBPC2	2.46e-05	2	173	2	36409445
Pubmed	Muscle CD31(-) CD45(-) side population cells promote muscle regeneration by stimulating proliferation and migration of myoblasts.	MMP2 DMD	2.46e-05	2	173	2	18669618
Pubmed	Characterization of the gene encoding mouse retinoblastoma binding protein-7, a component of chromatin-remodeling complexes.	RBBP4 RBBP7	2.46e-05	2	173	2	12376095
Pubmed	Generation and Characterization of an Abcc1 Humanized Mouse Model (hABCC1flx/flx ) with Knockout Capability.	ABCC1 ABCA7	2.46e-05	2	173	2	31189668
Pubmed	Interpreting the molecular mechanisms of RBBP4/7 and their roles in human diseases (Review).	RBBP4 RBBP7	2.46e-05	2	173	2	38577935
Pubmed	Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas.	PRUNE2 OBSCN	2.46e-05	2	173	2	17360660
Pubmed	The decrease of expression of ryanodine receptor sub-type 2 is reversed by gentamycin sulphate in vascular myocytes from mdx mice.	RYR2 DMD	2.46e-05	2	173	2	19298530
Pubmed	D-site binding protein transactivation requires the proline- and acid-rich domain and involves the coactivator p300.	DBP EP300	2.46e-05	2	173	2	10364202
Pubmed	Type I collagen stabilization of matrix metalloproteinase-2.	MMP2 COL1A1	2.46e-05	2	173	2	11368514
Pubmed	ATR inhibitors VE-821 and VX-970 sensitize cancer cells to topoisomerase i inhibitors by disabling DNA replication initiation and fork elongation responses.	ATR TOP1	2.46e-05	2	173	2	25269479
Pubmed	Complete sequence of human fast-type and slow-type muscle myosin-binding-protein C (MyBP-C). Differential expression, conserved domain structure and chromosome assignment.	MYBPC1 MYBPC2	2.46e-05	2	173	2	8375400
Pubmed	ZBTB7A Suppresses Melanoma Metastasis by Transcriptionally Repressing MCAM.	MCAM ZBTB7A	2.46e-05	2	173	2	25995384
Pubmed	Isoform-specific interaction of the myosin-binding proteins (MyBPs) with skeletal and cardiac myosin is a property of the C-terminal immunoglobulin domain.	MYBPC1 MYBPC2	2.46e-05	2	173	2	9252413
Pubmed	Cell surface chondroitin sulfate glycosaminoglycan in melanoma: role in the activation of pro-MMP-2 (pro-gelatinase A).	MMP2 MMP16	2.46e-05	2	173	2	17217338
Pubmed	RBBP4-p300 axis modulates expression of genes essential for cell survival and is a potential target for therapy in glioblastoma.	RBBP4 EP300	2.46e-05	2	173	2	35231103
Pubmed	Matrix metalloproteinase-2 ablation in dystrophin-deficient mdx muscles reduces angiogenesis resulting in impaired growth of regenerated muscle fibers.	MMP2 DMD	2.46e-05	2	173	2	21320869
Pubmed	Overlapping functions of RBBP4 and RBBP7 in regulating cell proliferation and histone H3.3 deposition during mouse preimplantation development.	RBBP4 RBBP7	2.46e-05	2	173	2	34709113
Pubmed	YTHDF1 regulates GID8-mediated glutamine metabolism to promote colorectal cancer progression in m6A-dependent manner.	YTHDF1 GID8	2.46e-05	2	173	2	39151722
Pubmed	Nanoscale remodeling of ryanodine receptor cluster size underlies cerebral microvascular dysfunction in Duchenne muscular dystrophy.	RYR2 DMD	2.46e-05	2	173	2	30181262
Pubmed	Type I collagen is a genetic modifier of matrix metalloproteinase 2 in murine skeletal development.	MMP2 COL1A1	2.46e-05	2	173	2	17440987
Pubmed	Elevated MMP2 abundance and activity in mdx mice are alleviated by prenatal taurine supplementation.	MMP2 DMD	2.46e-05	2	173	2	32208990
Pubmed	ZBTB7A suppresses glioblastoma tumorigenesis through the transcriptional repression of EPB41L5.	EPB41L5 ZBTB7A	2.46e-05	2	173	2	36596853
Pubmed	SIRT7 deacetylates DDB1 and suppresses the activity of the CRL4 E3 ligase complexes.	RBBP7 DCAF5 COPS5	2.57e-05	12	173	3	28886238
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	RBBP7 UBR4 EPB41L5 MTMR1 USP5 PTPN3 FAM120A CSK HNRNPUL2 P4HB AGL PTRH2 GID8 CDK1 DMD ZC3HAV1	3.17e-05	974	173	16	28675297
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	EVL PACSIN1 RBBP7 MTMR1 ACTR3B EDC4 GRAMD1B USP5 FAM120A C12orf50 HNRNPUL2 P4HB FAM120C RIMS1 FGG DMD DNAH6 TOP1 ARHGAP21 DNAH11	3.21e-05	1431	173	20	37142655
Pubmed	Histone deacetylase 3 modulates Tbx5 activity to regulate early cardiogenesis.	MYH7 MYH7B EP300	3.33e-05	13	173	3	24565863
Pubmed	Comparison of the gene expression profiles from normal and Fgfrl1 deficient mouse kidneys reveals downstream targets of Fgfrl1 signaling.	CLEC18A CLEC18B CLEC18C COL1A1	3.44e-05	37	173	4	22432025
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	EVL MACC1 MYH7 PDE6A NSD2 MYH7B UBR4 RYR2 P4HB CBX5 PES1 CAPRIN2 RIMS1 DMD DNAH6 TOP3B TOP1 ARHGAP21 MYBPC1 MYBPC2	3.57e-05	1442	173	20	35575683
Pubmed	Screen identifies bromodomain protein ZMYND8 in chromatin recognition of transcription-associated DNA damage that promotes homologous recombination.	RBBP4 RBBP7 DNAH9 EP300 BRWD1	3.74e-05	75	173	5	25593309
Pubmed	Identification of dynein heavy chain genes expressed in human and mouse testis: chromosomal localization of an axonemal dynein gene.	DNAH12 DNAH6 DNAH11	4.23e-05	14	173	3	9373155
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	MYH7 OBSCN FAM120A P4HB CBX5 AGL MED12L MMP2 ARHGAP21 MYBPC1 MYBPC2	4.29e-05	497	173	11	23414517
Pubmed	Proteomic analysis identifies novel binding partners of BAP1.	KLHDC2 RBBP4 RBBP7 FAT1 CBX5	5.11e-05	80	173	5	34591877
Pubmed	Loss of TRIM31 promotes breast cancer progression through regulating K48- and K63-linked ubiquitination of p53.	KRT9 RBBP7 YTHDF1 FAM120A HNRNPUL2 TSR1 PTRH2 FGG TOP1 COL1A1	5.35e-05	421	173	10	34650049
Pubmed	ATG5 is required for B cell polarization and presentation of particulate antigens.	EVL RBBP4 RBBP7 TUT7 TBC1D8B USP5 GTF2F2 FAM120A CSK CBX5 TOP1 CWF19L1 ZC3HAV1	5.36e-05	701	173	13	30196744
Pubmed	MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis.	RBBP4 NOL11 BCOR LIN9 GTF2F2 TSR1 PES1 NFRKB TOP1	5.46e-05	339	173	9	30415952
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	KRT9 RBBP4 TUT7 EXOSC3 NOL11 EDC4 MYOF PTPN3 GTF2F2 FAM120A HNRNPUL2 TSR1 P4HB PES1 CDK1 TOP1 ZC3HAV1 COL1A1	5.99e-05	1257	173	18	36526897
Pubmed	Structure-function relationship of Vpr: biological implications.	ATR CDK1 EP300	6.46e-05	16	173	3	19275588
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	MYH7 KRT9 RBBP4 RBBP7 UBR4 EXOSC3 MTMR1 AKR1A1 USP5 FAM120A TSR1 P4HB AGL CDK1 ZW10 TOP1 ZC3HAV1	6.52e-05	1149	173	17	35446349
Pubmed	The HIV-1 Tat protein recruits a ubiquitin ligase to reorganize the 7SK snRNP for transcriptional activation.	KRT9 RBBP4 RBBP7 CHD9 EDC4 YTHDF1 FAM120A HNRNPUL2 TSR1 P4HB CBX5 AGL CDK1 ZW10 TOP1 ZC3HAV1 COL1A1	6.81e-05	1153	173	17	29845934
Pubmed	The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA.	RBBP7 NSD2 EXOSC3 NOL11 FAM120A TSR1 CBX5 PES1 ZC3HAV1	6.82e-05	349	173	9	25665578
Pubmed	Increased matrix-metalloproteinase-2 and matrix-metalloproteinase-9 expression in the brain of dystrophic mdx mouse.	MMP2 DMD	7.36e-05	3	173	2	16650610
Pubmed	Collagen regulates the ability of endothelial progenitor cells to protect hypoxic myocardium through a mechanism involving miR-377/VE-PTP axis.	PTPRB COL1A1	7.36e-05	3	173	2	30044046
Pubmed	Comparative analysis of basal lamina type IV collagen α chains, matrix metalloproteinases-2 and -9 expressions in oral dysplasia and invasive carcinoma.	MMP2 COL1A1	7.36e-05	3	173	2	22694915
Pubmed	Dual retinoblastoma-binding proteins with properties related to a negative regulator of ras in yeast.	RBBP4 RBBP7	7.36e-05	3	173	2	7503932
Pubmed	Knockdown of MACC1 expression suppressed hepatocellular carcinoma cell migration and invasion and inhibited expression of MMP2 and MMP9.	MACC1 MMP2	7.36e-05	3	173	2	23232575
Pubmed	p300/CREB-binding protein interacts with ATR and is required for the DNA replication checkpoint.	ATR EP300	7.36e-05	3	173	2	17272271
Pubmed	An intrinsic S/G2 checkpoint enforced by ATR.	ATR CDK1	7.36e-05	3	173	2	30139873
Pubmed	Defective folding and stable association with protein disulfide isomerase/prolyl hydroxylase of type I procollagen with a deletion in the pro alpha 2(I) chain that preserves the Gly-X-Y repeat pattern.	P4HB COL1A1	7.36e-05	3	173	2	1339453
Pubmed	Preliminary evaluation for Bit1 as a potential biomarker for squamous cell carcinoma and adenocarcinoma of esophagus.	PTRH2 MMP2	7.36e-05	3	173	2	28488526
Pubmed	miR-582-5p inhibits proliferation of hepatocellular carcinoma by targeting CDK1 and AKT3.	AKT3 CDK1	7.36e-05	3	173	2	26002580
Pubmed	Structure of the RZZ complex and molecular basis of its interaction with Spindly.	ZWILCH ZW10	7.36e-05	3	173	2	28320825
Pubmed	Genetic inhibition of PKA phosphorylation of RyR2 prevents dystrophic cardiomyopathy.	RYR2 DMD	7.36e-05	3	173	2	20615971
Pubmed	The role of retinoblastoma-associated proteins 46 and 48 in estrogen receptor alpha mediated gene expression.	RBBP4 RBBP7	7.36e-05	3	173	2	18577416
Pubmed	A novel Akt3 mutation associated with enhanced kinase activity and seizure susceptibility in mice.	AKT3 FCGR2A	7.36e-05	3	173	2	21159799
Pubmed	Effects of combined Pulsed Dye Laser and Fractional CO2 Laser treatment of burn scars and correlation with plasma levels of collagen type I, MMP-2 and TIMP-1.	MMP2 COL1A1	7.36e-05	3	173	2	33358398
Pubmed	Expression of matrix metalloproteinases 2 and 9 in regenerating skeletal muscle: a study in experimentally injured and mdx muscles.	MMP2 DMD	7.36e-05	3	173	2	9882504
Pubmed	Sustained activation of P2X7 induces MMP-2-evoked cleavage and functional purinoceptor inhibition.	MMP2 DMD	7.36e-05	3	173	2	28992079
Pubmed	Matrix metalloproteinase gene polymorphisms and bronchopulmonary dysplasia: identification of MMP16 as a new player in lung development.	MMP2 MMP16	7.36e-05	3	173	2	18784838
Pubmed	Two-dimensional gel electrophoresis, protein electroblotting and microsequencing: a direct link between proteins and genes.	RBBP4 P4HB	7.36e-05	3	173	2	1699755
Pubmed	Age-related changes in collagen gene expression in the muscles of mdx dystrophic and normal mice.	DMD COL1A1	7.36e-05	3	173	2	7919967
Pubmed	Molecular cloning, functional expression, and chromosomal localization of mouse hepatocyte nuclear factor 1.	ACADS HPD	7.36e-05	3	173	2	2263635
Pubmed	Matrix metalloproteinase-2 inducing COL1A1 synthesis via integrin alpha Ⅴ promotes invasion and metastasis of cholangiocarcinoma cells.	MMP2 COL1A1	7.36e-05	3	173	2	38123132
Pubmed	LINC00941 promotes oral squamous cell carcinoma progression via activating CAPRIN2 and canonical WNT/β-catenin signaling pathway.	CAPRIN2 EP300	7.36e-05	3	173	2	32691935
Pubmed	Screening of MYH7, MYBPC3, and TNNT2 genes in Brazilian patients with hypertrophic cardiomyopathy.	MYH7 MYBPC1	7.36e-05	3	173	2	24093860
Pubmed	Leaky RyR2 trigger ventricular arrhythmias in Duchenne muscular dystrophy.	RYR2 DMD	7.36e-05	3	173	2	20080623
Pubmed	Zwilch, a new component of the ZW10/ROD complex required for kinetochore functions.	ZWILCH ZW10	7.36e-05	3	173	2	12686595
Pubmed	Acute inflammation plays a limited role in the regulation of adipose tissue COL1A1 protein abundance.	MMP2 COL1A1	7.36e-05	3	173	2	21775118
Pubmed	Matrix metalloproteinases mediate the dismantling of mesenchymal structures in the tadpole tail during thyroid hormone-induced tail resorption.	MMP2 MMP16	7.36e-05	3	173	2	11891989
Pubmed	Complex assembly, crystallization and preliminary X-ray crystallographic analysis of the human Rod-Zwilch-ZW10 (RZZ) complex.	ZWILCH ZW10	7.36e-05	3	173	2	25849506
Pubmed	The C-terminal IgI domains of myosin-binding proteins C and H (MyBP-C and MyBP-H) are both necessary and sufficient for the intracellular crosslinking of sarcomeric myosin in transfected non-muscle cells.	MYBPC1 MYBPC2	7.36e-05	3	173	2	12154082
Pubmed	HP1a/KDM4A is involved in the autoregulatory loop of the oncogene gene c-Jun.	CBX5 KDM4A	7.36e-05	3	173	2	25945750
Pubmed	Variation in Cilia Protein Genes and Progression of Lung Disease in Cystic Fibrosis.	DNAH14 DNAH6	7.36e-05	3	173	2	29323929
Pubmed	ATR promotes clearance of damaged DNA and damaged cells by rupturing micronuclei.	ATR CDK1	7.36e-05	3	173	2	37788673
Pubmed	The MTA1 subunit of the nucleosome remodeling and deacetylase complex can recruit two copies of RBBP4/7.	RBBP4 RBBP7	7.36e-05	3	173	2	27144666
Pubmed	Examining post-translational modification-mediated protein-protein interactions using a chemical proteomics approach.	RBBP4 RBBP7 CBX5	7.81e-05	17	173	3	23281010
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	ABCC1 ATR RBBP4 RBBP7 NSD2 EXOSC3 NOL11 BCOR LIN9 ZBTB7A POLR3E CBX5 NFRKB PTRH2 CDYL TOP1 EP300 ZC3HAV1	8.65e-05	1294	173	18	30804502
GeneFamily	Dyneins, axonemal	DNAH14 DNAH12 DNAH6 DNAH9 DNAH11	4.86e-08	17	112	5	536
GeneFamily	Fibronectin type III domain containing	OBSCN ANOS1 PTPRB PTPRQ MYBPC1 MYBPC2	4.83e-04	160	112	6	555
GeneFamily	Lysine methyltransferases\|Myb/SANT domain containing\|Polycomb repressive complex 2	RBBP4 RBBP7	5.61e-04	6	112	2	1347
GeneFamily	Topoisomerases	TOP3B TOP1	5.61e-04	6	112	2	1050
GeneFamily	Fibronectin type III domain containing\|I-set domain containing\|Myosin binding proteins	MYBPC1 MYBPC2	1.04e-03	8	112	2	658
GeneFamily	Histone deacetylases, class I\|EMSY complex\|NuRD complex\|SIN3 histone deacetylase complex	RBBP4 RBBP7	1.33e-03	9	112	2	1306
GeneFamily	Kelch like\|BTB domain containing	KLHL10 KLHL30 KLHL34	2.23e-03	42	112	3	617
GeneFamily	Histone deacetylases, class I\|EMSY complex\|NuRD complex\|SIN3 histone deacetylase complex	RBBP4 RBBP7	2.41e-03	12	112	2	1243
GeneFamily	PHD finger proteins\|NuRD complex	RBBP4 RBBP7	2.41e-03	12	112	2	1305
GeneFamily	WD repeat domain containing\|GRAM domain containing\|BEACH domain containing	TBC1D8B GRAMD1B	2.84e-03	13	112	2	1146
GeneFamily	C-type lectin domain family	CLEC18A CLEC18B CLEC18C	3.08e-03	47	112	3	494
GeneFamily	Ankyrin repeat domain containing\|FERM domain containing	FRMPD1 EPB41L5 PTPN3	3.67e-03	50	112	3	1293
GeneFamily	Myosin heavy chains	MYH7 MYH7B	3.79e-03	15	112	2	1098
GeneFamily	X-linked mental retardation\|Angiotensin receptors	BRWD3 ZDHHC15 DMD	4.33e-03	53	112	3	103
GeneFamily	WD repeat domain containing\|DDB1 and CUL4 associated factors	DCAF5 BRWD1	5.45e-03	18	112	2	498
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	DMD EP300	5.45e-03	18	112	2	91
GeneFamily	WD repeat domain containing	RBBP4 RBBP7 DCAF5 BRWD3 CFAP57 BRWD1	5.83e-03	262	112	6	362
GeneFamily	Protein tyrosine phosphatases, receptor type	PTPRB PTPRQ	7.40e-03	21	112	2	813
GeneFamily	Protein disulfide isomerases	P4HB PDILT	7.40e-03	21	112	2	692
GeneFamily	Endogenous ligands\|Matrix metallopeptidases	MMP2 MMP16	9.60e-03	24	112	2	891
GeneFamily	Phosphodiesterases	PDE6A PDE8B	9.60e-03	24	112	2	681
GeneFamily	Basic leucine zipper proteins\|BTB domain containing	KLHL10 ZBTB7A KLHL30 KLHL34	9.68e-03	134	112	4	861
Coexpression	HOWARD_NEUTROPHIL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP	GBP6 ATR VPS13C RCVRN EPB41L5 OAS2 GRAMD1B MSRB2 GBP4 MED12L NUB1 APOBEC3C TAP1 ZC3HAV1	3.95e-07	394	173	14	M40996
Coexpression	GSE10325_BCELL_VS_MYELOID_UP	EVL KLHDC2 BCL7A POLR3E CBX5 FAM3C MAPK13 TOP3B TCTN1	6.83e-06	197	173	9	M3081
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRUNE2 MCAM HPSE2 RYR2 EGFL6 MYOF FAT1 ATRNL1 RIMS1 DMD COL1A1	2.38e-10	189	174	11	7ab1cfc1657277858339f7258a0c4ae9cb42fdf8
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRUNE2 MCAM HPSE2 VAT1L RYR2 EGFL6 MYOF FAT1 ATRNL1 DMD COL1A1	2.66e-10	191	174	11	08042952431ca1a6fd7dfc13f36eb28643979598
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRUNE2 MCAM HPSE2 RYR2 EGFL6 MYOF FAT1 ATRNL1 DMD COL1A1	4.43e-09	191	174	10	7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRUNE2 MCAM HPSE2 RYR2 EGFL6 FAT1 ATRNL1 DMD COL1A1	6.93e-08	192	174	9	992d08092edbc68c47b945deb8708379738c239a
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|Control_saline / Treatment groups by lineage, cell group, cell type	PRUNE2 HPSE2 RYR2 MYOF FAT1 ATRNL1 MMP2 DMD COL1A1	9.82e-08	200	174	9	c5e051f1aac8dda376c342a9932785a23450e073
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic\|Control_saline / Treatment groups by lineage, cell group, cell type	PRUNE2 HPSE2 RYR2 MYOF FAT1 ATRNL1 MMP2 DMD COL1A1	9.82e-08	200	174	9	9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PRUNE2 HPSE2 RYR2 MYOF FAT1 ATRNL1 MMP2 DMD COL1A1	9.82e-08	200	174	9	8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PRUNE2 HPSE2 RYR2 EGFL6 MYOF FAT1 ATRNL1 DMD COL1A1	9.82e-08	200	174	9	67dcbd86fbc79fd585d0793f979e4aac100326c9
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Myocytic-Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRUNE2 FRMPD1 HPSE2 ABCA7 ATRNL1 DMD TCTN1	5.58e-07	123	174	7	87401764a073c1808f214642a9c84299c78f7ec7
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN RYR2 FAT1 TRPM3 PTPRQ DMD DNAH9 DNAH11	6.67e-07	184	174	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN RYR2 FAT1 TRPM3 PTPRQ DMD DNAH9 DNAH11	6.67e-07	184	174	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN RYR2 FAT1 TRPM3 PTPRQ DMD DNAH9 DNAH11	6.67e-07	184	174	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MCAM VAT1L RYR2 EGFL6 MYOF FAT1 ATRNL1 DMD	6.67e-07	184	174	8	327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MCAM STYXL2 RYR2 EGFL6 MFAP3L FAT1 DMD COL1A1	7.24e-07	186	174	8	4780af76237d7af2abbe2d8d5530cdf53e3ed0b7
ToppCell	facs-Marrow-B-cells-3m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH7 HPSE2 VAT1L IQCA1L TRPM3 ACSBG2 RIMS1	1.16e-06	137	174	7	4dcb15de821439011df1bb0bbd7682d674bd725d
ToppCell	facs-Marrow-B-cells-3m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH7 HPSE2 VAT1L IQCA1L TRPM3 ACSBG2 RIMS1	1.16e-06	137	174	7	c05ceeb7b483324604cb3f647d2da2b3786071b1
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PRUNE2 HPSE2 MYOF FAT1 ATRNL1 MMP2 DMD COL1A1	1.20e-06	199	174	8	e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PRUNE2 HPSE2 EGFL6 MYOF FAT1 ATRNL1 DMD COL1A1	1.25e-06	200	174	8	f599e4b051ac3dad11ad437e98dc8ea6754cca53
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_only / Treatment groups by lineage, cell group, cell type	PRUNE2 HPSE2 MYOF FAT1 ATRNL1 MMP2 DMD COL1A1	1.25e-06	200	174	8	593bf6a7c557437db9a9249a5058a46014179ef6
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PRUNE2 HPSE2 MYOF FAT1 ATRNL1 MMP2 DMD COL1A1	1.25e-06	200	174	8	87827041663013f5e7273168dc8709d69840e7ce
ToppCell	Control_saline-Mesenchymal_myocytic\|Control_saline / Treatment groups by lineage, cell group, cell type	HPSE2 RYR2 EGFL6 MYOF FAT1 ATRNL1 DMD COL1A1	1.25e-06	200	174	8	5ed4261157cd51109b314818133ac3a0d34ee5fa
ToppCell	LPS_only-Mesenchymal_myocytic\|LPS_only / Treatment groups by lineage, cell group, cell type	HPSE2 RYR2 EGFL6 MYOF FAT1 ATRNL1 DMD COL1A1	1.25e-06	200	174	8	8bc9923f82bfb836e2f524204c92050edeae8ca5
ToppCell	LPS_IL1RA-Mesenchymal_myocytic\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	HPSE2 EGFL6 MYOF FAT1 PDE8B ATRNL1 DMD COL1A1	1.25e-06	200	174	8	77631c471cc5d453a749784f838cfa6408caf09b
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Myocytic\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MCAM RYR2 EGFL6 FAT1 ATRNL1 MED12L DMD	2.75e-06	156	174	7	6365b69ede98bc866e996bc52736b00401aacf6f
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|kidney / Disease (COVID-19 only), tissue and cell type	KLHL10 PDE6A HPSE2 RYR2 SEL1L2 DMD DNAH9	3.68e-06	163	174	7	19c28ce16a588a7f4a035c32726f6ccd67702b5b
ToppCell	lung-Ciliated_Epithelia\|lung / shred on tissue and cell subclass	DCDC1 DNAH12 STPG1 ADGRF1 DNAH6 DNAH9 DNAH11	4.31e-06	167	174	7	26cf1cfa58ee74794449a87eb19cd896e1ec8892
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DCDC1 RAD51AP2 DNAH12 PDILT CFAP57 DNAH6 DNAH11	4.49e-06	168	174	7	9a8709d34865cfa668d8f3335dc34fc86fc32482
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DCDC1 DNAH12 MKX CFAP57 DNAH6 DNAH9 DNAH11	4.67e-06	169	174	7	fba841664939c771881ba97f14ef1df6635c04ff
ToppCell	droplet-Limb_Muscle-MUSCLE-30m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GBP6 VPS13C TUT7 PTPRB GBP4 TAP1 ZC3HAV1	6.56e-06	178	174	7	01dafd19de04eff459253eaa9a35debf8f3deedf
ToppCell	Control-Fibroblasts-Airway_smooth_muscle\|Control / group, cell type (main and fine annotations)	PRUNE2 MCAM HPSE2 RYR2 DMD MMP16 COL1A1	7.06e-06	180	174	7	d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1
ToppCell	droplet-Lung-nan-18m-Myeloid-Proliferating_Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 ZWILCH NSD2 ACTR3B TRPM3 MKX CDK1	7.06e-06	180	174	7	43fd5c498a87bb078d101298b472656f3294686a
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	FTCD BCOR RYR2 SLC12A1 TRPM3 HPD PTPRQ	7.32e-06	181	174	7	c80ffa2ded5975a88e9a1a7d333196f95237bf0a
ToppCell	COVID-19-kidney-Distal_Epi_Doublet_(PCT)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PRUNE2 FTCD MFAP3L PTPN3 SLC12A1 TRPM3 SCIN	7.58e-06	182	174	7	9d67717a6e13bcb54c1297a3e4e3abf4e51628a3
ToppCell	Adult-Epithelial-ciliated_cell-D122\|Adult / Lineage, Cell type, age group and donor	DCDC1 DNAH12 CFAP57 DNAH6 DNAH9 ODAD3 DNAH11	7.58e-06	182	174	7	7ded554a4b441e6496db673ba206c0d76ccad7d9
ToppCell	E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TTLL3 DNAH12 CFAP57 DNAH6 DNAH9 ODAD3 JHY	8.14e-06	184	174	7	797b6a6d6f6aafae98f75ca8bffe8263f8d3ff9b
ToppCell	Children_(3_yrs)-Epithelial-ciliated_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DCDC1 DNAH12 CFAP57 DNAH6 DNAH9 ODAD3 DNAH11	8.14e-06	184	174	7	5daff849625f2f41d56615569c0ed59cd733b34c
ToppCell	E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TTLL3 DNAH12 CFAP57 DNAH6 DNAH9 ODAD3 JHY	8.14e-06	184	174	7	77d5b60a20b277f589b18f7a131142a7ef2dac17
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRUNE2 HPSE2 FAT1 ATRNL1 RIMS1 DMD COL1A1	8.44e-06	185	174	7	e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3
ToppCell	Adult-Epithelial-ciliated_cell-D175\|Adult / Lineage, Cell type, age group and donor	DCDC1 DNAH12 CFAP57 DNAH6 DNAH9 ODAD3 DNAH11	8.44e-06	185	174	7	30f4980dee6cd5959655f8d74049f3bfb5312611
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRUNE2 HPSE2 RYR2 MYOF ATRNL1 DMD COL1A1	9.37e-06	188	174	7	3177b2c1723268d330d3e9f24f9e24492ace6286
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRUNE2 HPSE2 RYR2 ATRNL1 RIMS1 DMD COL1A1	9.37e-06	188	174	7	293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11
ToppCell	PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TTLL3 DNAH12 CFAP57 DNAH6 DNAH9 ODAD3 DNAH11	9.70e-06	189	174	7	02c6128a9ab5818e0881dcadafdad5f08b9a67cf
ToppCell	PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TTLL3 DNAH12 CFAP57 DNAH6 DNAH9 ODAD3 DNAH11	9.70e-06	189	174	7	164ea92ff6a1aa2ead1c9b8f64f99a9d65437232
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MCAM VAT1L RYR2 EGFL6 FAT1 DMD COL1A1	9.70e-06	189	174	7	975e7aa3b862a8b07c2ab8426a14f5cc54998aca
ToppCell	PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TTLL3 DNAH12 CFAP57 DNAH6 DNAH9 ODAD3 DNAH11	9.70e-06	189	174	7	a85099bd598a27ee64ee0664d051d89fa8d62fc9
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FRMPD1 HPSE2 VAT1L ANOS1 FAT1 CSK IL1RAP	1.07e-05	192	174	7	63d1b3efe93e5ff939278ebe40bacb38218ea09b
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MACC1 EPB41L5 DNAH14 PTPN3 FAT1 SLC12A1 TRPM3	1.15e-05	194	174	7	93c68c31e39fa44c1d05d7d4997f4f086da4e738
ToppCell	control-Myeloid-Neutrophils_2\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	OAS2 ALPK1 GBP4 FCGR2A NUB1 TAP1 ZC3HAV1	1.15e-05	194	174	7	267e213e8efe53aadfe553a2ca010a0e3b4b8939
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	GBP6 DCDC1 DNAH12 CFAP57 DNAH6 DNAH9 DNAH11	1.15e-05	194	174	7	756082a0f5953b52229bb60d40b84701cb6cb23d
ToppCell	moderate-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DCDC1 DNAH12 CFAP57 DNAH6 DNAH9 TCTN1 DNAH11	1.19e-05	195	174	7	3486eae5fdb062a75a907b896c9d7b396d2aa195
ToppCell	moderate-Epithelial-Ciliated\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DCDC1 DNAH12 CFAP57 DNAH6 DNAH9 TCTN1 DNAH11	1.19e-05	195	174	7	e80f5cdf0b18066b3e6c2f5452e58f101c67932c
ToppCell	critical-Epithelial-Ciliated\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DCDC1 DNAH12 CFAP57 DNAH6 DNAH9 TCTN1 DNAH11	1.23e-05	196	174	7	27b855c6e1ae44f16db998cf0e81bd686b9cee7e
ToppCell	NS-control-d_0-4-Epithelial-Ciliated\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DCDC1 DNAH12 CFAP57 DNAH6 DNAH9 TCTN1 DNAH11	1.23e-05	196	174	7	d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a
ToppCell	PSB-critical-LOC-Epithelial-Ciliated\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DCDC1 DNAH12 CFAP57 DNAH6 DNAH9 TCTN1 DNAH11	1.27e-05	197	174	7	6865f4831eb23794fb88a8649d48d497bbae3f44
ToppCell	NS-moderate-d_0-4-Epithelial-Ciliated\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DCDC1 DNAH12 CFAP57 DNAH6 DNAH9 TCTN1 DNAH11	1.27e-05	197	174	7	71fea4aa6ce96c7693fa94792d08770622873850
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DCDC1 DNAH12 CFAP57 DMD DNAH6 DNAH9 DNAH11	1.27e-05	197	174	7	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	control-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DCDC1 DNAH12 CFAP57 DNAH6 DNAH9 TCTN1 DNAH11	1.27e-05	197	174	7	e453d085182364ca347cbcc9dc995c62c3353016
ToppCell	control-Epithelial-Ciliated\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DCDC1 DNAH12 CFAP57 DNAH6 DNAH9 TCTN1 DNAH11	1.27e-05	197	174	7	d4e963c1f82996371bf3d63578ee9fce8e00c5a8
ToppCell	critical-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DCDC1 DNAH12 CFAP57 DNAH6 DNAH9 TCTN1 DNAH11	1.31e-05	198	174	7	ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	OBSCN MCAM RYR2 EGFL6 FAT1 PDE8B DMD	1.40e-05	200	174	7	0c648941447c738caf62f2d71e296d6cca492c8b
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	OBSCN MCAM RYR2 EGFL6 FAT1 PDE8B DMD	1.40e-05	200	174	7	522a51a284d2992d519c4669e1a48c8ebcc08c80
ToppCell	VE\|World / Condition, Cell_class and T cell subcluster	VPS13C OAS2 GBP4 CSK NUB1 TAP1 TOP1	1.40e-05	200	174	7	8ae7cb81de3ffac5acdf3466d4b516d80cac95d3
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	OBSCN MCAM RYR2 EGFL6 FAT1 PDE8B DMD	1.40e-05	200	174	7	94f1fa61aa82eb9f411b2b1cb759476939ab5db7
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PRUNE2 HPSE2 MYOF FAT1 ATRNL1 DMD COL1A1	1.40e-05	200	174	7	c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PRUNE2 HPSE2 FAT1 ATRNL1 MMP2 DMD COL1A1	1.40e-05	200	174	7	08bf8c00eee6468215edb3611296bfc8784c4d56
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic\|LPS_only / Treatment groups by lineage, cell group, cell type	PRUNE2 HPSE2 FAT1 ATRNL1 MMP2 DMD COL1A1	1.40e-05	200	174	7	02cae2c296a13ad4cbb53bca7a86d64629d67d66
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PRUNE2 HPSE2 FAT1 ATRNL1 MMP2 DMD COL1A1	1.40e-05	200	174	7	dcdaec3ca3a3024dc1b8788c417003f84c2bffdc
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Cilia-bearing_cell\|6m / Sample Type, Dataset, Time_group, and Cell type.	DCDC1 DNAH12 TRPM3 DNAH6 DNAH9 JHY DNAH11	1.40e-05	200	174	7	177f9ad8dd8635394c575a2b30140184df0bd51e
ToppCell	PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TUT7 BMX PTPRB SLC12A1 ADGRF1 TRPV5	2.03e-05	142	174	6	191a13bba143ecdfc2bfd797c3ac191481388298
ToppCell	PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	TUT7 BMX PTPRB SLC12A1 ADGRF1 TRPV5	2.11e-05	143	174	6	b405dba9a83a99cc7b53ce71772bc52a0bbb0d4e
ToppCell	Ciliated_cells-A-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	GBP6 DCDC1 ZNF20 DNAH12 DNAH6 DNAH9	2.87e-05	151	174	6	9d03ce73af15ef40c592d19b36aff46bebc14c40
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	RBBP7 FRMPD1 PTPN3 SEL1L2 UQCR11 TRPV5	3.09e-05	153	174	6	79c4f4ccdc8249c8461075c73491bc3b2d13344a
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	HPSE2 RYR2 SEL1L2 RIMS1 DMD DNAH9	3.84e-05	159	174	6	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY8 RYR2 SLC12A1 PTPRQ MKX DNAH9	3.98e-05	160	174	6	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY8 RYR2 SLC12A1 PTPRQ MKX DNAH9	3.98e-05	160	174	6	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	Adult-Mesenchymal-airway_smooth_muscle_cell-D122\|Adult / Lineage, Cell type, age group and donor	PRUNE2 MCAM HPSE2 RYR2 ACSBG2 DMD	4.12e-05	161	174	6	64891f6f2ee1693c8481e951b9346e2f92d602e3
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c5-GSTP1(high)OASL(low)\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CLEC18A OAS2 GBP4 MED12L TAP1 ZC3HAV1	4.41e-05	163	174	6	d005115aa1e1458b51de7eb719794617a4168608
ToppCell	368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	ATOH7 VAT1L MFAP3L ANOS1 RIMS1 SCIN	5.22e-05	168	174	6	e870d2e69316406f45112ed0bf324b24f902a99e
ToppCell	E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FRMPD1 DNAH12 CFAP57 DNAH6 DNAH9 ODAD3	5.22e-05	168	174	6	fa7c0303918cea04e3f4c4f3cb079be19004d214
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L3-5_THEMIS_UBE2F\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PRUNE2 DNAH14 MKX CDK1 DNAH6 MYBPC1	5.22e-05	168	174	6	bfa1491e8d433933003778b274710d3a16d973cb
ToppCell	368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	ATOH7 VAT1L MFAP3L ANOS1 RIMS1 SCIN	5.22e-05	168	174	6	403aba73a0f9ffb32252288d075fad8a588ca440
ToppCell	E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FRMPD1 DNAH12 CFAP57 DNAH6 DNAH9 ODAD3	5.22e-05	168	174	6	7edcab103c69e928d5c19a0d218ffb3ae32f9e70
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DCDC1 DNAH12 CFAP57 DNAH6 DNAH9 DNAH11	5.39e-05	169	174	6	14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	OBSCN HPSE2 RYR2 KLHL30 RIMS1 MYBPC2	5.57e-05	170	174	6	cb1ed6bd409ee1cf11be0d5e7cdcffe2ab220d38
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	OBSCN HPSE2 RYR2 KLHL30 RIMS1 MYBPC2	5.57e-05	170	174	6	da4fb1e186e9bec6bba0b25f2a0e68f9e11c6017
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PRUNE2 MCAM HPSE2 RYR2 DMD MMP16	6.14e-05	173	174	6	cb6389536195443633adb06e5f1b7483530773d1
ToppCell	3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DCDC1 DNAH12 CFAP57 DNAH6 DNAH9 DNAH11	6.14e-05	173	174	6	c3762655caa79ac4879876f470d32578a3c93b01
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VPS13C CHD9 RYR2 CBX5 DMD ARHGAP21	6.75e-05	176	174	6	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	facs-Trachea-nan-18m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH7 TTLL3 CFAP57 DNAH6 DNAH9 DNAH11	6.75e-05	176	174	6	ed788a5969edfd1199828ca5b0dd34e7f29c4d30
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TTLL3 ALPK1 KLHL30 CAPRIN2 DNAH9 DNAH11	6.97e-05	177	174	6	e8bb4f8ecd5e283efec966b9fc2040a6152d5551
ToppCell	Fetal_29-31_weeks-Epithelial-ciliated_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DCDC1 DNAH12 DNAH6 DNAH9 ODAD3 DNAH11	7.19e-05	178	174	6	de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6
ToppCell	droplet-Fat-BAT+GAT+MAT-30m-Epithelial-epithelial_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLEC18A FTCD ADCY8 ACSBG2 CFAP57 JHY	7.19e-05	178	174	6	b0baf5667e3301898b3e45e974b8a8530af6a338
ToppCell	droplet-Fat-BAT+GAT+MAT-30m-Epithelial\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLEC18A FTCD ADCY8 ACSBG2 CFAP57 JHY	7.19e-05	178	174	6	58857bb8c13e0e1c6d9f5c1258f00fff62063d68
ToppCell	droplet-Fat-BAT+GAT+MAT-30m-Epithelial-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLEC18A FTCD ADCY8 ACSBG2 CFAP57 JHY	7.19e-05	178	174	6	8b7df6ab8709d9ab9dff97677cc4561aec2745bc
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DCDC1 DNAH12 CFAP57 DNAH6 DNAH9 DNAH11	7.19e-05	178	174	6	3b12db04006db6e94fc45649a4b3a63b92f21a61
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MACC1 EPB41L5 MYOF ANOS1 TRPM3 PTPRQ	7.41e-05	179	174	6	04ce3673e46606f63d9c87bcba3a64c96817d812
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 MACC1 FTCD ADCY8 FAT1 TRPM3	7.41e-05	179	174	6	58ae5a97fe2a14e1c6fdeb886397eb06fdaf0428
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HPSE2 ATRNL1 RIMS1 MMP2 DMD COL1A1	7.41e-05	179	174	6	02c90d8306016365ed811f0c63cfb3ac7b85464c
ToppCell	human_hepatoblastoma-Tumor_cells-T6\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	PRUNE2 ABCC1 MYH7B RYR2 TRPM3 CFAP57	7.41e-05	179	174	6	14fc8ccb6b215063d747643f47d780d2b237eb67
ToppCell	VE-mono2-\|VE / Condition, Cell_class and T cell subcluster	SLC12A1 FCGR2A MKX SEL1L2 MMP2 SCIN	7.64e-05	180	174	6	188e7c65e9a86771f89029b18dfb3216b2c9d7d7
Drug	Benzydamine hydrochloride [132-69-4]; Down 200; 11.6uM; PC3; HT_HG-U133A	NUDT2 ALPK1 MSRB2 MYOF HNRNPUL2 PDE8B MMP16 JHY COL1A1 BRWD1	2.27e-06	197	169	10	5811_DN
Disease	distal arthrogryposis (implicated_via_orthology)	MYH7 MYH7B MYBPC1	7.57e-05	15	166	3	DOID:0050646 (implicated_via_orthology)
Disease	Cohen syndrome (implicated_via_orthology)	VPS13C VPS13B	9.40e-05	3	166	2	DOID:0111590 (implicated_via_orthology)
Disease	myopathy (implicated_via_orthology)	MYH7 MYH7B MTMR1 MYBPC2	1.55e-04	48	166	4	DOID:423 (implicated_via_orthology)
Disease	fat body mass	PRUNE2 DOK2 ACTR3B ADCY8 MKX MED12L NUB1	2.38e-04	217	166	7	EFO_0005409
Disease	magnesium measurement	DCDC1 ALPK1 ADCY8 CANT1	5.31e-04	66	166	4	EFO_0004845
Disease	cardiomyopathy (is_marker_for)	MMP2 EP300	6.49e-04	7	166	2	DOID:0050700 (is_marker_for)
Disease	behavioural disinhibition measurement	SEL1L2 MMP2 DNAH9 DNAH11	8.61e-04	75	166	4	EFO_0006946
Disease	Embryonal Rhabdomyosarcoma	BCOR DMD	8.61e-04	8	166	2	C0206656
Disease	Malignant neoplasm of breast	EVL ABCC1 NSD2 UBR4 FRMPD1 NUDT2 OBSCN STPG1 WBP4 MMP2 DMD DNAH9 TOP1 EP300 VPS13B	1.13e-03	1074	166	15	C0006142
Disease	autosomal dominant hyaline body myopathy (implicated_via_orthology)	MYH7 MYH7B	1.37e-03	10	166	2	DOID:0111269 (implicated_via_orthology)
Disease	distal arthrogryposis type 2B3 (implicated_via_orthology)	MYH7 MYH7B	1.37e-03	10	166	2	DOID:0111602 (implicated_via_orthology)
Disease	distal arthrogryposis type 1 (implicated_via_orthology)	MYH7 MYH7B	1.37e-03	10	166	2	DOID:0111596 (implicated_via_orthology)
Disease	dilated cardiomyopathy 1S (implicated_via_orthology)	MYH7 MYH7B	1.37e-03	10	166	2	DOID:0110454 (implicated_via_orthology)
Disease	congenital myopathy 6 (implicated_via_orthology)	MYH7 MYH7B	1.37e-03	10	166	2	DOID:0080719 (implicated_via_orthology)
Disease	inclusion body myositis (implicated_via_orthology)	MYH7 MYH7B	1.37e-03	10	166	2	DOID:3429 (implicated_via_orthology)
Disease	distal arthrogryposis type 2A (implicated_via_orthology)	MYH7 MYH7B	1.37e-03	10	166	2	DOID:0111605 (implicated_via_orthology)
Disease	familial hypertrophic cardiomyopathy (implicated_via_orthology)	MYH7 MYH7B	1.37e-03	10	166	2	DOID:0080326 (implicated_via_orthology)
Disease	dilated cardiomyopathy (is_marker_for)	OBSCN MMP2 DMD	1.38e-03	39	166	3	DOID:12930 (is_marker_for)
Disease	red blood cell density measurement	DCDC1 ATR ACADS EPB41L5 BCL7A ZBTB7A PTPN3 TRPM3 KLHL30 PDE8B KDM4A TOP1 VPS13B	1.48e-03	880	166	13	EFO_0007978
Disease	Nephrosclerosis	ALPK1 COL1A1	1.67e-03	11	166	2	C0027719
Disease	diffuse scleroderma (is_implicated_in)	FCGR2A TAP1	1.67e-03	11	166	2	DOID:1580 (is_implicated_in)
Disease	Tumoral calcinosis	MMP2 DMD COL1A1	1.71e-03	42	166	3	C0263628
Disease	Calcinosis	MMP2 DMD COL1A1	1.71e-03	42	166	3	C0006663
Disease	Microcalcification	MMP2 DMD COL1A1	1.71e-03	42	166	3	C0521174
Disease	distal myopathy (implicated_via_orthology)	MYH7 MYH7B	2.00e-03	12	166	2	DOID:11720 (implicated_via_orthology)
Disease	AL amyloidosis	GRAMD1B DNAH11	2.00e-03	12	166	2	MONDO_0019438
Disease	myotonia congenita (implicated_via_orthology)	MYH7 MYH7B	2.00e-03	12	166	2	DOID:2106 (implicated_via_orthology)
Disease	Colorectal Carcinoma	EVL ABCC1 TTLL3 OBSCN ADCY8 FAT1 CBX5 PDILT MMP2 DMD EP300	2.17e-03	702	166	11	C0009402
Disease	response to angiotensin-converting enzyme inhibitor, Cough	ACTR3B MMP16 VPS13B	2.22e-03	46	166	3	EFO_0005325, HP_0012735
Disease	restrictive cardiomyopathy (implicated_via_orthology)	MYH7 MYH7B	2.36e-03	13	166	2	DOID:397 (implicated_via_orthology)
Disease	Osteogenesis Imperfecta	P4HB COL1A1	2.36e-03	13	166	2	C0029434
Disease	Osteosarcoma	BCOR MMP2 ZW10	2.36e-03	47	166	3	C0029463
Disease	Primary Ciliary Dyskinesia	DNAH9 ODAD3 DNAH11	2.36e-03	47	166	3	C4551720
Disease	response to antineoplastic agent	UBR4 ADCY8 RYR2 COL1A1	2.40e-03	99	166	4	GO_0097327
Disease	Disease Exacerbation	ABCC1 ABCA7 MMP2 IL1RAP TOP1	2.47e-03	165	166	5	C0235874
Disease	ocular hypertension, response to triamcinolone acetonide	TTLL3 TUT7 CHD9	2.66e-03	49	166	3	EFO_0006954, EFO_1001069
Disease	Kartagener syndrome (implicated_via_orthology)	ODAD3 DNAH11	2.74e-03	14	166	2	DOID:0050144 (implicated_via_orthology)
Disease	Left ventricular noncompaction	MYH7 MYH7B	2.74e-03	14	166	2	C1960469
Disease	amenorrhea, response to antineoplastic agent	ADCY8 RIMS1	3.15e-03	15	166	2	EFO_0010269, GO_0097327
Disease	temporal arteritis (is_implicated_in)	FCGR2A MMP2	3.58e-03	16	166	2	DOID:13375 (is_implicated_in)
Disease	Glioblastoma Multiforme	AKT3 ZBTB7A FAT1 MMP2	3.63e-03	111	166	4	C1621958
Disease	Muscle hypotonia	NSD2 NUDT2	4.05e-03	17	166	2	C0026827
Disease	Hypertrophic Cardiomyopathy	MYH7 OBSCN RYR2	4.10e-03	57	166	3	C0007194
Disease	syndrome (implicated_via_orthology)	NSD2 ZDHHC15	4.54e-03	18	166	2	DOID:225 (implicated_via_orthology)
Disease	Oral Submucous Fibrosis	MMP2 COL1A1	4.54e-03	18	166	2	C0029172
Disease	colorectal cancer (is_implicated_in)	BCOR YTHDF1 FAT1 EP300	4.93e-03	121	166	4	DOID:9256 (is_implicated_in)
Disease	Colorectal Neoplasms	EVL ABCC1 FAT1 CBX5 MMP2 EP300	4.93e-03	277	166	6	C0009404
Disease	renal system measurement	DCDC1 PDILT	5.59e-03	20	166	2	EFO_0004742
Disease	Fetal Growth Retardation	NSD2 MMP2	5.59e-03	20	166	2	C0015934

Protein segments in the cluster

Peptide	Gene	Start	Entry
TYPALASKNGKKWEI	ACSBG2	66	Q5FVE4
IGAKKPQYDIWGKTV	ADCY8	1101	P40145
YDKKQQQEILAAKPW	COPS5	31	Q92905
TIKRKLDTGQYQEPW	EP300	1101	Q09472
WEKQKEQPKEYQRIL	ATG4A	101	Q8WYN0
SEDEKWKTGKIQLYQ	EGFL6	496	Q8IUX8
VKGQVEYLLKWKGFS	CBX5	31	P45973
PILKFGSKEQKQAWV	ACADS	126	P16219
KPLYSWEEAKQKTVE	HSD3B1	341	P14060
RKFIDWKGIPVNKSQ	ADGRF1	426	Q5T601
VQLGKWKGQYDVAVK	BMX	431	P51813
DVDPRKWIKQYTGIN	ACTR3B	246	Q9P1U1
PKWRATYEDQQIKKI	FAM47DP	251	A6NHR8
WKDKPLVKVTFFQNG	FCGR2A	146	P12318
VYNDNEPFKPWKGLK	APOBEC3C	161	Q9NRW3
IDPQQQGIKWIKNKY	DNAH11	3496	Q96DT5
RKSKIYSVNLQKQPW	BRWD3	961	Q6RI45
ADPNKKWVQKYISDL	CCL18	71	P55774
VTKDPNWYKAKNKVG	CSK	41	P41240
NWYKAKNKVGREGII	CSK	46	P41240
WKEGPYTVDAIQKKI	DMD	2606	P11532
NKPKTVIYWLAEVKD	NUDT2	86	P50583
WNQGKTVVKSDKLVY	BCOR	791	Q6W2J9
SWVKNLAQYGKPIKN	GKN3P	121	P0CG01
KQPWGLVKTFIEKNF	GRAMD1B	506	Q3KR37
QGLKTKKWVNEVRYG	ABCA7	1401	Q8IZY2
SGVNWQDVYDKKLVP	AKT3	406	Q9Y243
WQYKQAVGPEDKTNL	ALPK1	66	Q96QP1
KPKWDKNQITYRIIG	MMP2	116	P08253
YKRQGLPNESWKISK	MTMR1	236	Q13613
IYWSQNRPDVKKQKL	RAD51AP2	296	Q09MP3
ILDWVPYINGKFKKD	UQCR11	41	O14957
KLELTAKQYPDIWNK	RIC1	291	Q4ADV7
AKQYPDIWNKTGAVK	RIC1	296	Q4ADV7
NKVKIQPVAKYDWEQ	EDC4	116	Q6P2E9
KKLLPQEKNVLSQYW	PTPN3	311	P26045
VDYNIIGWLQKNKDP	MYH7	586	P12883
KKVYVYDPGANLWQK	KLHL30	481	Q0D2K2
QLWKPPYTDENKKVG	NUB1	21	Q9Y5A7
YKVSDQKPLGSWSVK	NOL11	46	Q9H8H0
VESGQIYKNPVTWLK	ANKRD31	1736	Q8N7Z5
TIQNEWKVYVKKPLD	FAT1	2971	Q14517
KNNKDTNKYEGWPEV	FAM3C	201	Q92520
LQVKVYWKKTEDPTV	ANOS1	441	P23352
PLSLKNEQKIWVSYG	DCDC1	566	M0R2J8
LILYNPNGTKKENWK	PTPRB	1206	P23467
KPDGVYIEEVLSKWK	OGFRL1	131	Q5TC84
WQPGTEYDNVVLKKG	DOK2	396	O60496
LYVLGPEEQVWSKKA	KLHL34	496	Q8N239
PQFKWYNSIGKLLKE	MFAP3L	76	O75121
EKYSSLQKTPVWKGR	LIN9	31	Q5TKA1
GIYQQKFLKEPSKTW	MAEL	251	Q96JY0
KKKPQVNAKDNYWLV	MED12L	91	Q86YW9
WPEEYNKALEGDKTK	MAGEE2	281	Q8TD90
LRYDPNWKSKKEEGQ	JHY	126	Q6NUN7
SPFVEFKEKTQQWKL	NFRKB	446	Q6P4R8
LENKIQDWYDKKGPA	KRT9	181	P35527
QDWYDKKGPAAIQKN	KRT9	186	P35527
LTVIKWKGEKSKYPQ	IL1RAP	521	Q9NPH3
DQKIISYLWEKTQGP	KIAA0319L	626	Q8IZA0
YNVDQKWQKFIPGSE	CFAP57	41	Q96MR6
AEWEEYKTGIKKAPI	CWF19L1	51	Q69YN2
VNENPEWVKVVGYKG	CANT1	241	Q8WVQ1
VVPYSIVGWLEKNKD	MYH7B	631	A7E2Y1
LDTWYVIKPGNTKEK	FBXO46	86	Q6PJ61
KGPSKDDTYWKEINA	MKX	296	Q8IYA7
TEQYKWLEIKEGKLG	KIAA1586	146	Q9HCI6
QKILKTREVYGKEPW	PDE6A	466	P16499
INTCIKKGKEWQGVY	PDE8B	331	O95263
YDDTSKKWVPIKPGQ	EVL	16	Q9UI08
QYPETKIIKTDGKGW	NSD2	1061	O96028
TQWALKYAKENPEKR	HNRNPUL2	466	Q1KMD3
SGVEKIIKIWSPYKQ	DCAF5	351	Q96JK2
NTWYPKVINLFTKKE	DNAH12	261	Q6ZR08
PERYKLWKAGKDNTV	KDM4A	326	O75164
KQDVNKTAWELPKTY	MAPK13	11	O15264
QEGKLYWGDAKTDKI	LRP5L	131	A4QPB2
QVEWDYKLVPRKGVK	GBP4	456	Q96PP9
YWQVPRKGVKAKEVF	GBP6	446	Q6ZN66
IIKEWAAYKGKSPQT	FAM120A	641	Q9NZB2
KQLAPIWDKLGETYK	P4HB	401	P07237
TIKNVEPKQELKVWY	PRDM10	311	Q9NQV6
KVVNTYTPGKKIWLE	HPSE2	366	Q8WWQ2
VPAQKLGWFIQEYLK	OAS2	11	P29728
VINEEYKIWKKNTPF	RBBP4	16	Q09028
INEEYKIWKKNTPFL	RBBP7	16	Q16576
KWDPPKKANGIITQY	PTPRQ	1401	Q9UMZ3
KIEKAYGQQLTDWAK	PACSIN1	51	Q9BY11
VLPGQLSVKLWYDKV	RIMS1	741	Q86UR5
VKKILEPKWNQTFVY	RIMS1	801	Q86UR5
QAQTEVTWYKDGKKL	OBSCN	916	Q5VST9
AQPQTEVTWYKDGKK	OBSCN	1191	Q5VST9
QAQTEVTWYKDGKKL	OBSCN	1376	Q5VST9
PKPVISWYKDGKAVQ	OBSCN	6041	Q5VST9
GSVDFKKNWIQYKEG	FGG	226	P02679
QKSTDWSGVKKPIYL	ATR	1466	Q13535
PSNIWKKIDQSRDYK	CHD9	841	Q3L8U1
IFEKWKEYRGQTPAQ	EPB41L5	201	Q9HCM4
YLGPLKTRVDEWQKQ	DNAH6	1076	Q9C0G6
VSPAYLKKWSAKGIQ	GDE1	281	Q9NZC3
GWNNTEKKVYNIPGI	KLHL10	71	Q6JEL2
KKNWQYEGPTQKLFL	CDYL	16	Q9Y232
AQPQKISLKYIEKDW	FRMPD1	321	Q5SYB0
KDYWQKQPQLKLKET	C3orf38	96	Q5JPI3
VILKEWSAYKGKSPQ	FAM120C	691	Q9NX05
WAQNELDQKKVKYPK	GID8	201	Q9NWU2
VVPQWGQDKKLSKYE	ATOH7	66	Q8N100
KYTQQKVSPWVGLRK	ATRNL1	801	Q5VV63
EKLLYKPQAGEWGQK	BRWD1	1146	Q9NSI6
QWKQDTPKSKAGYVQ	CAPRIN2	471	Q6IMN6
WYPEKNPDKLTKIIQ	DNAH14	1751	Q0VDD8
VKAIGQSKVKEWYVG	MACC1	586	Q6ZN28
QSKVKEWYVGVLRGK	MACC1	591	Q6ZN28
PPSSKDKLGVWVYKN	KLHDC2	141	Q9Y2U9
KIQVPEEQKDEKYWS	DBP	246	Q10586
VDPQLQGIKWIKNKY	DNAH9	3466	Q9NYC9
YKWVPVTEPKVDDKN	BCL7A	46	Q4VC05
PESAFWKKIIAYQQK	RYR2	4476	Q92736
VQGNWVVKSDILYPK	POLR3E	321	Q9NVU0
WVDSQQKRYVPVKGD	EXOSC3	101	Q9NQT5
LKKVQGIGWYLDEKN	FTCD	216	O95954
QVIWYKNGRPLKEEK	MCAM	171	P43121
QKEWNPSLFKVLYKT	ABCC1	306	P33527
PKYWDQGLVKQLVGK	PDILT	381	Q8N807
PWVEQDKFGKVKFAV	HPD	121	P32754
VKVPKYLSQQWAKAS	GTF2F2	21	P13984
GLYKEGQNWLEKKDV	SEC11C	136	Q9BY50
PKTRGKVYEKVDSWN	PRUNE2	906	Q8WUY3
KQIFVWKGKDANPQE	SCIN	291	Q9Y6U3
NTPEKRAEKIWKYFG	RCVRN	146	P35243
KYFQKAAEKGWPDAQ	SEL1L2	396	Q5TEA6
WIGNAEKNFYKKTPK	IQCA1L	626	A6NCM1
KWEKPYLKNRTGQAL	ODAD3	136	A5D8V7
SQVEKGSYPWQVSLK	OVCH2	56	Q7RTZ1
KTLTNKWYEEVRQGP	SLC9A8	556	Q9Y2E8
YKKNWRKAPLTEIEN	SLC12A1	781	Q13621
LPKKVGKWYQLLEVQ	TAP1	341	Q03518
NKVEVQYKTLPGWNT	ADSS2	396	P30520
TWKSEPGQVKAAVKY	AKR1A1	21	P14550
VESLQDYKNTFPKWK	CDK1	231	P06493
GVKKRKWIYDEPQNF	C12orf50	286	Q8NA57
GNWEVNGKTIVPYKK	CLEC18A	186	A5D8T8
GNWEVNGKTIIPYKK	CLEC18B	186	Q6UXF7
GNWEVNGKTIVPYKK	CLEC18C	186	Q8NCF0
SVAQKNWYISKNPKD	COL1A1	1306	P02452
KQWEYCGQPKVVVKA	PTRH2	106	Q9Y3E5
FLGKYNKWDKVDPAE	TOP3B	66	O95985
PTGKWQLKVSNDGYK	VWDE	1011	Q8N2E2
EKPQKWRVEIYSGQK	ZWILCH	526	Q9H900
VGKTWKVQNIEDEYK	ZNF20	46	P17024
KKVPKGTSSYQAEWI	TSR1	391	Q2NL82
RPKKWSVVNFLGKEY	ZSCAN5DP	121	P0CG00
EYWKFNNQILKVEPG	MMP16	506	P51512
KSEWQKKLTPEQFYV	MSRB2	51	Q9Y3D2
WNTVERLKDNKPNYK	PES1	101	O00541
KGKGKIDIQAYLSQW	TBC1D8B	956	Q0IIM8
KPDLYKESWKNNPAI	TTI2	211	Q6NXR4
LPGKQSFLYNEDKKW	STPG1	316	Q5TH74
PGKLLQKVKVWLQEY	TRPM3	951	Q9HCF6
EEEKLYEQWKKGQGL	STYXL2	346	Q5VZP5
YEQWKKGQGLLSDKV	STYXL2	351	Q5VZP5
VKWTKYGSLLNPQAK	TCTN1	511	Q2MV58
KTLKKSNPYGEWQEI	WBP4	286	O75554
TLKIPWKNLYGEAVV	VPS13C	66	Q709C8
KLVVKSEWKSYPIQA	TTLL3	156	Q9Y4R7
LYNQKKIKPVVDSLW	VAT1L	341	Q9HCJ6
KSLQPIWPYNKKDSD	VPS13B	2941	Q7Z7G8
GTWIQYGEEKDKRKN	ZC3HAV1	616	Q7Z2W4
YKGEKKPEIFVDGWN	TUT7	1196	Q5VYS8
KIYGKTKEQFGWPDE	UBR4	2421	Q5T4S7
PDSNGEKKQTYKWSG	ARHGAP21	516	Q5T5U3
IGKKWKPQNIYVEYE	ZNF433	46	Q8N7K0
PSSRIKGEKDWQKYE	TOP1	431	P11387
IQIKKFTFGLDWVPK	USP5	571	P45974
DGDVYPAWSQKVEKK	ZBTB7A	361	O95365
TPVKELVSFKWNKYG	TRPV5	311	Q9NQA5
KGKFDVQWIFVKDVP	YTHDF1	471	Q9BYJ9
QQVFGDKKKFWLIPI	ZDHHC15	271	Q96MV8
NKKYQEEVPVYVPKW	ZW10	706	O43264
KYTWNDVGQLVEKLK	AGL	191	P35573
YVKGWIPGNEENKQK	MYOF	1816	Q9NZM1
LADPKLEVKWYKNGQ	MYBPC1	276	Q00872
LEVKWYKNGQEIRPS	MYBPC1	281	Q00872
KVTGKWYKNGVEVRP	MYBPC2	466	Q14324